LAWRENCE, Mass., May 9, 2011 /PRNewswire/ — NxStage Medical,
Inc. (Nasdaq:
NXTM), a leading manufacturer of innovative dialysis products,
today expressed its support for an initiative by three patient
advocacy groups to educate U.S. Congressional policymakers and
their advisors about the benefits of home dialysis, including
frequent home hemodialysis.
(Logo:
http://photos.prnewswire.com/prnh/20110503/MM94799LOGO)
On Tuesday, May 10th, delegations from the National Kidney
Foundation, Friends of the Congressional Kidney Caucus and
NxStageUsers Group will host a special briefing for Congresspersons
and their staff, where they will present important new developments
and studies indicating marked improvement in kidney patient health
particularly through advances in frequent home hemodialysis.
NxStageUsers is an independent patient group that has no
organizational or fiduciary relationships with NxStage Medical,
Inc.
“NxStage is committed to ensuring that every dialysis patient is
informed about and has equal access to all appropriate treatment
options, including more frequent home hemodialysis,” said Jeffrey
H. Burbank, Chief Executive Officer of NxStage Medical, Inc. “The
growing body of independent clinical data documenting the lower
mortality, improved quality of life, and other significant clinical
benefits made possible uniquely with more frequent hemodialysis
provides overwhelming evidence in support of this therapy.
Access to more frequent hemodialysis at home for all patients
who might benefit should be a priority for providers, payors and
policymakers.”
About NxStage
NxStage Medical, Inc. (Nasdaq:
NXTM) is a medical device company, headquartered in Lawrence,
Massachusetts, USA, that develops, manufactures and markets
innovative products for the trea
‘/>”/>
